AI-generated drug cures deadly cancer in children
Scientists have used Artificial Intelligence (AI) to develop the drug against the rare form of deadly brain cancer in children.
The team of scientists, doctors, and data analysts at the Institute of Cancer Research (ICR), London have successfully used artificial intelligence for the creation of a drug for children with the rare form of brain cancer called Diffuse Intrinsic Pontine Glioma (DIPG). This is a deadly form of cancer in which the survival rate has not improved for 50 years. The journal of Cancer Discovery revealed this major breakthrough in the field of cancer research. This discovery can further help in the development of new treatments for all types of cancer.
No doubt this breakthrough is a big step in the field of discovering a cure for cancer. Professor Kristian Helin, Chief Executive of The Institute of Cancer Research (ICR) London said “The use of AI promises to have a transformative effect on drug discovery.” She furthermore termed this discovery as a future treatment for children suffering from this incurable brain cancer.“In this study, the use of AI has identified a drug combination that appears to have promise as a future treatment for some children with incurable brain cancer. It’s exciting to think that it could become one of the first examples of a treatment proposed by AI going on to benefit patients.”
For now, DIPG and other forms of similar cancer can be very difficult to remove via surgery creating a huge risk of patient death. This research study was funded by Brain Research UK, the DIPG collaborative, children with Cancer UK, and the Royal Marsden Cancer Charity
Artificial Intelligence is transforming the field of medicine with its widespread applications and benefits. From taking care of patients to synthesizing data for future predictions, AI is serving the healthcare field in the most effective and efficient manner. Now a large number of doctors and clinicians rely upon AI and ML-powered healthcare apps and software for surgeries, diagnostics, and drug discovery. The reason AI is becoming popular is because of its ability to assess details that might escape the human eye as Chris Jones professor of pediatric brain tumor biology at the ICR also highlights the importance of AI in this research said: “Our study demonstrates just how much AI can bring to drug discovery for cancers like DIPG, in proposing new treatment combinations that would not have been obvious to people.”
The combination of drugs developed is initially tested on four children. And now experts hope to test this drug on a large group of children in clinical trials. Artificial Intelligence is also being used in the treatment of brain diseases etc.